Protective and therapeutic effects ot swimming exercise training on diabetic peripheral neuropathy of streptozotocin-induced diabetic rats

Journal of Endocrinological Investigation

Volumn 31, Issue 11, 2008, Pages 971-978

  Selagzi, H ^a   Buyukakilli, B ^a   Cimen, B ^a   Yilmaz, N ^a   Erdogan, S ^a  

^a MERSIN UNIVERSITY   (Turkey)

Author keywords

Action potential; Diabetic peripheral neuropathy; Swimming exercise training

Indexed keywords

GLUCOSE; MYELIN; STREPTOZOCIN;

AEROBIC EXERCISE; AMPLITUDE MODULATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEMYELINATION; DIABETIC NEUROPATHY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HISTOPATHOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; KINESIOTHERAPY; LATENT PERIOD; MALE; MORPHOMETRICS; MOTOR DYSFUNCTION; MUSCLE ACTION POTENTIAL; NEUROPROTECTION; NONHUMAN; PHYSICAL ACTIVITY; RAT; SCIATIC NERVE; STREPTOZOCIN DIABETES; SWIMMING; THERAPY EFFECT; WEIGHT REDUCTION;

EID: 59849113027     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03345634     Document Type: Article

References (38)

1. Sugimura K, Windebank AJ, Natarajan V, Lambert EH, Schmid HH, Dyck PJ. Interstitial hyperosmolarity may cause axis cylinder shrinkage in streptozotocin-diabetic nerve. J Neuropathol Exp Neurol 1980, 39: 710-21.
2. Yasuda H, Terada M, Maeda K, et al. Diabetic neuropathy and nerve regeneration. Prog Neurobiol 2003, 69: 229-85.
3. Boulton AJ. Lowering the risk of neuropathy, foot ulcers and amputations. Diabet Med 1998, 15 (Suppl 4): 557-9.
4. Poncelet AN. Diabetic polyneuropathy. Risk factors, patterns of presentation, diagnosis, and treatment. Geriatrics 2003, 58: 16-8.
5. Cameron NE, Cotter MA. The relationship of vascular changes to metabolic factors in diabetes mellitus and their role in the development of peripheral nerve complications. Diabetes Metab Rev 1994, 10: 189-224.
6. Ward JD. Biochemical and vascular factors in the pathogenesis of diabetic neuropathy. Clin Invest Med 1995, 18: 257-74.
7. Kim J, Kyriazi H, Greene DA. Normalization of Na+-K+ ATPase activity in isolated membrane fraction from sciatic nerves of streptozotocin-induced diabetic rats by dietary myoinositol supplementation in vivo or protein kinase C agonists in vitro. Diabetes 1991, 40: 558-57.
8. Bianchi R, Buyukakilli B, Brines M, et al. Erythropoietin both protects from and reverses experimental diabetic neuropathy. Proc Natl Acad Sci USA 2004, 101: 823-8.
9. Naziroglu M, Simsek M, Kutlu M. Moderate exercise with a dietary vitamin C and E combination protects against streptozotocin-induced oxidative damage to the blood and improves fetal outcomes in pregnant rats. Clin Chem Lab Med 2004, 42: 511-7.
10. Lee DM, Hoffman WH, Carl GF, Khichi M, Cornwell PE. Lipid peroxidation and antioxidant vitamins prior to, during, and after correction of diabetic ketoacidosis. J Diabetes Complications 2002, 16: 294-300.
11. Atalay M, Laaksonen DE. Diabetes, oxidative stress and physical exercise. J Sports Sci Med 2002, 1: 1-14.
12. Dahl-Jørgensen K, Brinchmann-Hansen O, Hanssen KF, et al. Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: The Oslo study. Br Med J (Clin Res Ed) 1986, 293: 1195-9.
13. Richardson JK, Sandman D, Vela S. A focused exercise regimen improves clinical measures of balance in patients with peripheral neuropathy. Arch Phys Med Rehabil 2001, 82: 205-9.
14. Balducci S, Iacobellis G, Parisi L, et al. Exercise training can modify the natural history of diabetic peripheral neuropathy. J Diabetes Complications 2006, 20: 216-23.
15. Thomas PK, Tomlinson DR. Diabetic and hypoglycemic neuropathy. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF eds. Peripheral Neuropathy (vol 3). Philadelphia: WB Saunders. 1993, 1219-50.
16. Tesfaye S, Harris ND, Wilson RM, Ward JD. Exercise-induced conduction velocity increment: a marker of impaired peripheral nerve blood flow in diabetic neuropathy. Diabetologia 1992, 35: 155-9.
17. Harri M, Kuusela P. Is swimming exercise or cold exposure for rats? Acta Physiol Scand 1986, 126: 189-97.
18. Gobatto CA, de Mello MA, Sibuya CY, de Azevedo JR, dos Santos LA, Kokubun E. Maximal lactate steady state in rats submitted to swimming exercise. Comp Biochem Physiol A Mol Integr Physiol 2001, 130: 21-7.
19. de Oliveira CA, Luciano E, de Mello MA. The role of exercise on long-term effects of alloxan administered in neonatal rats. Exp Physiol 2004, 90: 79-86.
20. Matsuo T, Kang HS, Suzuki H, Suzuki M. Voluntary resistance exercise improves blood hemoglobin concentration in severely iron-deficient rats. J Nutr Sci Vitaminol (Tokyo) 2002, 48: 161-4.
21. Aminoff MJ. Nerve conduction studies: Basic principles and pathologic correlations. In Aminoff MJ ed. Electromyography in Clinical Practice. London: Churchill Livingstone 1998, 113-45.
22. Rakieten N, Rakieten ML, Nadkarni MV. Studies on the diabetogenic action of streptozotocin (NSC-37917). Cancer Chemother Rep 1963, 29: 91-8.
23. Changrani NR, Chonkar A, Adeghate E, Singh J. Effects of streptozotocin-induced type 1 diabetes mellitus on total protein concentrations and cation contents in the isolated pancreas, parotid, submandibular, and lacrimal glands of rats. Ann N Y Acad Sci 2006, 1084: 503-19.
24. Andriambeloson E, Baillet C, Vitte PA, Garotta G, Dreano M, Callizot N. Interleukin-6 attenuates the development of experimental diabetes-related neuropathy. Neuropathology 2006, 26: 32-42.
25. Vinik Al. Diabetic neuropathy: pathogenesis and therapy. Am J Med 1999, 107 (2B): 17S-26S.
26. Coskun O, Ocakci A, Bayraktaroglu T, Kanter M. Exercise training prevents and protects streptozotocin-induced oxidative stress and beta-cell damage in rat pancreas. Tohoku J Exp Med 2004, 203: 145-54.
27. Wallberg-Henriksson H, Gunnarsson R, Henriksson J, et al. Increased peripheral insulin sensitivity and muscle mitochondrial enzymes but unchanged blood glucose control in type I diabetes after physical training. Diabetes 1982, 31: 1044-50.
28. Franz MJ. Exercise and the management of diabetes mellitus. J Am Diet Assoc 1987, 87: 872-80.
29. Carrington AL, Calcutt NA, Ettlinger CB, Gustafsson T, Tomlinson DR. Effects of treatment with myo-inositol or its 1,2,6-trisphosphate (PP56) on nerve conduction in streptozotocin-diabetes. Eur J Pharmacol 1993: 237: 257-63.
30. Lee HH, Shin MS, Kim YS, et al. Early treadmill exercise decreases intrastriatal hemorrhage-induced neuronal cell death and increases cell proliferation in the dentate gyrus of streptozotocin-induced hyperglycemic rats. J Diabetes Complications 2005, 19: 339-46.
31. Kihara M, Mitsui MK, Mitsui Y, et al. Altered vasoreactivity to angiotensin II in experimental diabetic neuropathy: role of nitric oxide. Muscle Nerve 1999, 22: 920-5.
32. Tomlinson DR, Holmes PR, Mayer JH. Reversal, by treatment with an aldose reductase inhibitor, of impaired axonal transport and motor nerve conduction velocity in experimental diabetes mellitus. Neurosci Lett 1982, 31: 189-93.
33. Saini AK, Arun KH, Kaul CL, Sharma SS. Acute hyperglycemia attenuates nerve conduction velocity and nerve blood flow in male Sprague-Dawley rats: reversal by adenosine. Pharmacol Res 2004, 50: 593-9.
34. Yang O, Kaji R, Takagi T, et al. Abnormal axonal inward rectifier in streptozocin-induced experimental diabetic neuropathy. Brain 2001, 124: 1149-55.
35. Greene DA, Feldman EL, Stevens MJ, Sima AAF, Albers JW, Pfeifer MA. Diabetic neuropathy. In: Porte D, Sherwin R eds. Ellenberg & Rifkins's diabetes mellitus. Stamford (CO): Appleton & Lange. 1997, 1009-76.
36. Kjeldsen K, Richter EA, Galbo H, Lortie G, Clausen T. Training increases the concentration of [3H]ouabain-bindin9 sites in rat skeletal muscle. Biochim Biophys Acta 1986, 860: 708-12.
37. Bestetti G, Zemp C, Probst D, Rossi GL. Neuropathy and myopathy in the diaphragm of rats after 12 months of streptozotocin-induced diabetes mellitus. A light-, electron-microscopic, and morphometric study. Acta Neuropathol 1981, 55: 11-20.
38. Birrell AM, Heffernan SJ, Ansselin AD, et al. Functional and structural abnormalities in the nerves of type I diabetic baboons: aminoguanidine treatment does not improve nerve function. Diabetologia 2000, 43: 110-6.